HuGE Literature Finder
Records
1
-
30
| Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of hepatology 2023 1 28 (2): 100898. Yang Zhao, Liu Jianwei, Xue Feng, Zhang Lei, Xue Hui, Wu Yeye, Bai Shilei, Du Furong, Wang Xiaoxuan, Deng Wanglong, Song Chao, Wang K |
| Useful genes for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma. Journal of cancer research and therapeutics 2023 1 18 (7): 1860-1866. Guo Yuan, Hu Hongtao, Xu Shijun, Xia Weili, Li Hailia |
| Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma. BMC cancer 2022 Oct 22 (1): 1046. Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Otsuka Shimpei, Ohnami Sumiko, Nagashima Takeshi, Hatakeyama Keiichi, Sugino Takashi, Urakami Kenichi, Akiyama Yasuto, Yamaguchi K |
| Analysis of MUC6 Genetic Variants on the Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma. Journal of Cancer 2022 9 13 (11): 3251-3257. Lee Hsiang-Lin, Chien Yi-Chung, Wang Hsiang-Ling, Hua Chun-Hung, Liu Liang-Chih, Wu Guo-Wei, Bai Li-Yuan, Yang Shun-Fa, Yu Yung-Lu |
| Association of the MARCO polymorphism rs6761637 with hepatocellular carcinoma susceptibility and clinical characteristics. Immunologic research 2022 4 70 (3): 400-407. Su Zhenzhen, Luo Limei, Wu Xiaojuan, Wei Bin, Wang Lu, Liu Fei, Cai B |
| Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing. Journal of gastrointestinal oncology 2022 9 13 (4): 1864-1874. Li Qi, Zhang Qifan, Chen Jinzhang, Zang Mengya, Hu Xiaoyun, Li Rong, Hou Jinlin, Zhou J |
| CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence. BMC cancer 2022 8 22 (1): 884. Ambrozkiewicz Filip, Trailin Andriy, ?ervenková Lenka, Vaclavikova Radka, Hanicinec Vojtech, Allah Mohammad Al Obeed, Palek Richard, T?eška Vladislav, Daum Ondrej, Tonar Zbyn?k, Liška Václav, Hemminki Ka |
| Down-regulation of TRPV6 Is Associated With Adverse Prognosis in Hepatocellular Carcinoma Treated With Curative Resection. Cancer genomics & proteomics 2022 2 19 (2): 259-269. Koh Hyun Hee, Choi Sangjoon, Park Cheol-Keun, Ha Sang Y |
| Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma. Frontiers in oncology 2022 7 12 893107. Zhang Youfu, Wang Xuyang, Wang Huaxiang, Jiang Yi, Xu Zhidan, Luo Laiba |
| Hepatitis B Virus Pregenomic RNA Reflecting Viral Replication in Distal Non-tumor Tissues as a Determinant of the Stemness and Recurrence of Hepatocellular Carcinoma. Frontiers in microbiology 2022 4 13 830741. Xiao Yiwei, Cao Junning, Zhang Ze, Zeng Chaoting, Ou Guomin, Shi Jihang, Liu Zhixiu, Li Yi, Deng Juan, Xu Yinzhe, Zhang Wenwen, Li Jie, Li Tong, Zhuang Hui, Lu Shichun, Xiang Kuanh |
| Identification of DNA methylation signatures for hepatocellular carcinoma detection and microvascular invasion prediction. European journal of medical research 2022 12 27 (1): 276. Hao Yijie, Yang Qingxia, He Qiye, Hu Huanjing, Weng Zongpeng, Su Zhixi, Chen Shuling, Peng Sui, Kuang Ming, Chen Zhihang, Xu Lix |
| Matrix metalloproteinase 12 (MMP12) as an adverse prognostic biomarker of vascular invasion in hepatic cell carcinoma. European review for medical and pharmacological sciences 2022 4 26 (7): 2238-2249. Guo Z-Y, Jiang L |
| Methylation site APC112043544 as a potential biomarker for post-transplant hepatocellular carcinoma recurrence. Future oncology (London, England) 2022 5 18 (19): 2401-2413. Yang Zhentao, Chen Wei, Zhu Hai, Zhang Liang, Zhou Ke, Tang Hong, Sun Ruiqi, Huang Yiqian, Xie Haiyang, Zheng Shusen, Jia Chang |
| Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. Journal of hepato-biliary-pancreatic sciences 2022 8 . Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Nagashima Takeshi, Yamaguchi K |
| Overexpression of chaperonin containing TCP1 subunit 7 has diagnostic and prognostic value for hepatocellular carcinoma. Aging 2022 1 14 (2): 747-769. Huang Xinghua, Wang Huaxiang, Xu Fengfeng, Lv Lizhi, Wang Ruling, Jiang Bin, Liu Tingting, Hu Huanzhang, Jiang |
| Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period. Hepatology international 2022 1 16 (1): 135-147. Kaibori Masaki, Sakai Kazuko, Matsushima Hideyuki, Kosaka Hisashi, Matsui Kosuke, De Velasco Marco A, Sekimoto Mitsugu, Nishio Kazu |
| Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in hepatocellular carcinoma. Cancer medicine 2022 12 . Su Renyi, Zhang Huizhong, Zhang Lincheng, Khan Abdul Rehman, Zhang Xuanyu, Wang Rui, Shao Chuxiao, Wei Xuyong, Xu Xi |
| TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma. Cancer biology & therapy 2022 12 23 (1): 439-445. Li Yong, Wu Junjun, Li Enliang, Xiao Zhouqing, Lei Jun, Zhou Fan, Yin Xiangbao, Hu Dandan, Mao Yilei, Wu Linquan, Wenjun Li |
| Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management. Cancers 2022 8 14 (16): . Higuera Mónica, Vargas-Accarino Elena, Torrens María, Gregori Josep, Salcedo María Teresa, Martínez-Campreciós Joan, Torres Gloria, Bermúdez-Ramos María, Bilbao Itxarone, Guerrero-Murillo Mercedes, Serres-Créixams Xavier, Merino Xavier, Rodríguez-Frías Francisco, Quer Josep, Mínguez Beatr |
| Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence. Hepatology international 2022 12 . Shi Huizhong, Zhang Wenwen, Hu Bingyang, Wang Yafei, Zhang Ze, Sun Ying, Mao Guankun, Li Chonghui, Lu Shich |
| Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation. Journal, genetic engineering & biotechnology 2021 Nov 19 (1): 174. Salum Ghada M, El Meguid Mai Abd, Abelhafez Tawfeek H, Medhat Eman, Abdel Aziz Ashraf O, Dawood Reh |
| Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma. Aging 2021 Sep 13 (undefined): . Chen Xi, Zhang Minfeng, Li Nan, Pu Rui, Wu Ting, Ding Yibo, Cai Peng, Zhang Hongwei, Zhao Jun, Yin Jianhua, Cao Guangw |
| Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas. JHEP reports : innovation in hepatology 2021 Aug 3 (4): 100326. Chopinet Sophie, Cauchy François, Hobeika Christian, Beaufrère Aurélie, Poté Nicolas, Farges Olivier, Dokmak Safi, Bouattour Mohamed, Ronot Maxime, Vilgrain Valérie, Paradis Valérie, Soubrane Olivi |
| Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population. Hepatobiliary & pancreatic diseases international : HBPD INT 2021 Jul . Guo Xin-Yi, Xia Yi-Lin, Li Zhi-Yang, Li Ran, Fan Yang, Yao Wen-Mo, Liu F |
| Genetic Polymorphisms in CD35 Gene Contribute to the Susceptibility and Prognosis of Hepatocellular Carcinoma. Frontiers in oncology 2021 11 700711. Luo Limei, Li Qin, Su Zhenzhen, Li Lixin, Cai Bei, Peng Yufu, Bai Yangjuan, Liu F |
| Influence of the ABO Blood Group System on Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation 2021 12 106 (7): 1411-1420. Mohkam Kayvan, Abdallah Raëf, N'kontchou Gisèle, Ganne Nathalie, Barbier Louise, Salamé Ephrem, Bucur Petru, Rayar Michel, Robin Fabien, Boudjema Karim, Pietrasz Daniel, Cherqui Daniel, Adam René, Lim Chetana, Savier Eric, Scatton Olivier, Maulat Charlotte, Suc Bertrand, Muscari Fabrice, Laurent Alexis, Duvoux Christophe, Heyd Bruno, Turco Célia, Doussot Alexandre, Merle Philippe, Antonini Teresa, Lesurtel Mickaël, Cossé Cyril, Durand François, Soubrane Olivier, Cauchy François, Mabrut Jean-Yves, |
| Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study. Molecular biology reports 2021 11 49 (2): 1609-1616. Pommergaard H C, Yde C W, Ahlborn L B, Andersen C L, Henriksen T V, Hasselby J P, Rostved A A, Sørensen C L, Rohrberg K S, Nielsen F C, Rasmussen |
| Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor-related factors. Transplant international : official journal of the European Society for Organ Transplantation 2021 11 34 (12): 2875-2886. Orci Lorenzo A, Combescure Christophe, Fink Michael, Oldani Graziano, Compagnon Philippe, Andres Axel, Berney Thierry, Toso Christi |
| Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study. Molecular oncology 2021 9 16 (2): 549-561. Zhu Gui-Qi, Liu Wei-Ren, Tang Zheng, Qu Wei-Feng, Fang Yuan, Jiang Xi-Fei, Song Shu-Shu, Wang Han, Tao Chen-Yang, Zhou Pei-Yun, Huang Run, Gao Jun, Sun Hai-Xiang, Ding Zhen-Bin, Peng Yuan-Fei, Dai Zhi, Zhou Jian, Fan Jia, Shi Ying-Ho |
| SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer. Biomedicines 2021 12 9 (12): . Chu Yu-De, Kee Kwong-Ming, Lin Wey-Ran, Lai Ming-Wei, Lu Sheng-Nan, Chung Wen-Hung, Pang See-Tong, Yeh Chau-Ti |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: